RT Journal Article
SR Electronic
T1 Soluble IL-2R contributes to impaired muscle cell mitochondrial respiration in fatigued individuals with post-acute sequelae of COVID
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.14.24311980
DO 10.1101/2024.08.14.24311980
A1 Brown, Laura P.
A1 Joshi, Jai
A1 Kosmac, Kate
A1 Long, Douglas E.
A1 Montgomery-Yates, Ashley A.
A1 Kalema, Anna G.
A1 Sturgill, Jamie L.
A1 Vekaria, Hemendra
A1 Sullivan, Patrick
A1 Wilburn, Dylan
A1 Koutakis, Panagiotis
A1 Latham, Christine M.
A1 Fry, Christopher S.
A1 Kern, Philip A.
A1 Miller, Benjamin
A1 Dupont-Versteegden, Esther E.
A1 Ismaeel, Ahmed
A1 Mayer, Kirby P.
A1 Wen, Yuan
YR 2024
UL http://medrxiv.org/content/early/2024/08/19/2024.08.14.24311980.abstract
AB Post-acute sequelae of COVID (PASC) persist in many patients for weeks and months after recovery from initial SARS-CoV-2 infection. Recent evidence suggests that pathological changes in skeletal muscle may contribute significantly to ongoing pain and fatigue, particularly post-exertional malaise. This study aimed to investigate the underlying mechanisms of PASC-related fatigue by examining skeletal muscle function and circulating factors in affected individuals.We conducted a cross-sectional case-control study of patients with fatigue-associated PASC who had experienced mild to moderate COVID-19 without hospitalization. Skeletal muscle biopsies revealed reduced mitochondrial respiration and content in PASC participants compared to healthy controls. This lower respiratory capacity was accompanied by markedly elevated circulating levels of soluble IL-2 receptor alpha subunit (sIL2R), a T cell-specific receptor.In vitro experiments demonstrated that sIL2R directly impairs mitochondrial oxygen consumption and reduces mitochondrial complex III subunit protein levels in cultured muscle cells. These findings suggest a mechanism linking systemic immune dysregulation to muscle-specific mitochondrial dysfunction in PASC.This work provides new insights into the pathophysiology of PASC identifying sIL2R as a promising therapeutic target for addressing mitochondrial deficits in PASC-related fatigue and opening avenues for developing targeted interventions.Competing Interest StatementYuan Wen is the owner of MyoAnalytics, LLC. The other authors have no conflict of interests to report.Funding StatementThe project was supported by the Pilot Grant Program of the Office of Research and Scholarship of the College of Health Sciences, University of Kentucky. The project was supported by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998. KPM is supported by NIAMS (K23-AR079583). EED, JLS, PK, AGK, AMY, and KPM are supported by NIAMS and NIGMS (R01-AR081002). YW and LPB are supported by NIAMS (R00-AR081367).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional review board at the University of Kentucky gave ethical approval for this work (MEDFL 42971,43046, 43499, 46072).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.